LONDON, April 21 /PRNewswire/ --     Evaluate Ltd, the parent company of EvaluatePharma(R), the premier online
analysis service for the global pharmaceutical industry, is announced today
as a winner of the coveted Queen's Award for Enterprise in International
Trade.

The Queen's Awards for Enterprise are the UK's most
prestigious Awards for business performance. They recognise and reward
outstanding achievement by UK companies. In receiving the Award, London based
Evaluate Ltd has been recognised for demonstrating outstanding growth in
overseas earnings for a company of its size. In the last three years sales of
the EvaluatePharma(R) service have more than doubled outside the UK. As a
result, the EvaluatePharma(R) service has grown to serve users located across
the globe including New York, New Jersey, Tokyo, Basel, Berlin, Paris and
London. This is an impressive pace of growth for a company that began life
only twelve years ago working out of a run down business centre in south west
London.

At the company's headquarters in London, CEO and Founder Dr.
Jonathan de Pass said, "We are enormously proud to receive our first Queen's
Award for Enterprise and it is an impressive achievement by all our staff
both here in the UK and in the US. Our growth has focused on the US, Swiss
and German markets and is a reflection of our innovative approach to
providing clients with unique, reliable and fast solutions to their
analytical needs."

Dr. de Pass, a former top-ranked Pharmaceutical analyst in the
City of London, set up Evaluate Ltd in 1996 to provide reliable and
comprehensive pharma business data to investment analysts and industry
insiders, "Our rapid growth in the last few years has allowed us to invest in
our people, and our proprietary software platform, to deliver the highest
quality service to our clients. We now have over 35 UK based employees with a
dedicated team of in-house analysts and software programmers, plus sales and
client support teams based in the UK and US. The Queen's Award for Enterprise
is high and public recognition so winning this Award is an honour for
everyone involved."

Evaluate Ltd's loyal and growing client base includes the top
global pharma and biotech companies, the investment banking community and the
leading global management consulting firms. The Company intends to launch
more innovative developments to the EvaluatePharma(R) service throughout 2009
as it continues to build upon its success and focuses on bringing even
greater value to its clients.

Notes to Editors:

Evaluate Ltd is the parent company of EvaluatePharma(R), the
premier online analysis service for the global pharmaceutical and
biotechnology sector.

Set up in 1996 by Dr. Jonathan de Pass, EvaluatePharma(R)
provides proprietary insight into the commercial and financial prospects of
the pharma and biotech industry and was the first company to provide reliable
consensus forecasts of global drug sales. EvaluatePharma's powerful
proprietary software platform offers a user friendly web interface that makes
complex analysis simple, providing analysis and insights not available
anywhere else. In 2007 EvaluatePharma(R)Alpha was launched offering a
valuation service designed to quantify market events and the impact on
product, portfolio and company valuation.

EvaluatePharma(R), EvaluatePharma(R)Alpha, and EP Vantage are
services of EvaluatePharma Ltd, headquartered in London, England. In North
America, EvaluatePharma Ltd is represented by EvaluatePharma USA, Inc
(Wilmington, Delaware).

Contact:

    Joanna Southward
    +44(0)20-7539-5413
    joannas@evaluatepharma.com

    Andrew Beaven
    +44(0)20-7539-1818
    andrewb@evaluatepharma.com